These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3536386)
1. [Regression of coronary sclerosis in familial hypercholesterolemia IIa by specific LDL apheresis]. Hombach V; Borberg H; Gadzkowski A; Oette K; Stoffel W Dtsch Med Wochenschr; 1986 Nov; 111(45):1709-15. PubMed ID: 3536386 [TBL] [Abstract][Full Text] [Related]
2. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group. Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308 [TBL] [Abstract][Full Text] [Related]
3. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis]. Schuff-Werner P Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722 [TBL] [Abstract][Full Text] [Related]
4. Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient. Jansen M; Gabriel H; Banyai S; Pidlich J; Weidinger F; Hörl WH; Derfler K Wien Klin Wochenschr; 1996; 108(14):425-31. PubMed ID: 8784984 [TBL] [Abstract][Full Text] [Related]
5. Long term effect of LDL apheresis on coronary heart disease. Donner MG; Richter WO; Schwandt P Eur J Med Res; 1997 Jun; 2(6):270-4. PubMed ID: 9182655 [TBL] [Abstract][Full Text] [Related]
6. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy]. Seidel D Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597 [TBL] [Abstract][Full Text] [Related]
7. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis. Borberg H; Gaczkowski A; Hombach V; Oette K; Stoffel W Prog Clin Biol Res; 1988; 255():317-26. PubMed ID: 3340643 [No Abstract] [Full Text] [Related]
8. Extracorporeal treatment of hypercholesterolaemia. Olbricht CJ Nephrol Dial Transplant; 1993; 8(9):814-20. PubMed ID: 8255513 [TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis in familial hypercholesterolemia. Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429 [TBL] [Abstract][Full Text] [Related]
10. [LDL apheresis in the treatment of hyperlipoproteinemia]. Ishikawa K Nihon Rinsho; 1994 Dec; 52(12):3298-302. PubMed ID: 7853726 [TBL] [Abstract][Full Text] [Related]
11. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods]. Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708 [TBL] [Abstract][Full Text] [Related]
12. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis. Mol MJ; Stalenhoef AF Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495 [TBL] [Abstract][Full Text] [Related]
13. [Effect of the LDL-/HDL-cholesterol quotient on progression and regression of arteriosclerotic lesions. An analysis of controlled angiographic intervention studies]. Gohlke H Wien Klin Wochenschr; 1992; 104(11):309-13. PubMed ID: 1621390 [TBL] [Abstract][Full Text] [Related]
14. [H.E.L.P. apheresis and oxidative stress]. Pulawski E; Mellwig KP; Horstkotte D Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600 [TBL] [Abstract][Full Text] [Related]
15. Apheresis technologies for prevention and regression of atherosclerosis: clinical results. Bambauer R; Schneidewind JM; Latza R ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615 [TBL] [Abstract][Full Text] [Related]